Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 08-2016 | |
| Sales | 385 | 223 | 433 | 64 | 41 |
| Cost of Goods | 99 | 23 | 25 | 30 | 46 |
| Gross Profit | 285 | 200 | 408 | 34 | -5 |
| Operating Expenses | 4,273 | 4,260 | 7,008 | 1,895 | 1,211 |
| Operating Income | -3,988 | -4,060 | -6,600 | -1,861 | -1,216 |
| Interest Expense | N/A | N/A | 0 | 6 | 2 |
| Other Income | -96 | -99 | -9 | -62 | -59 |
| Pre-tax Income | -4,085 | -4,158 | -6,609 | -1,929 | -1,277 |
| Net Income Continuous | -4,085 | -4,158 | -6,609 | -1,929 | -1,277 |
| Minority Interests | 151 | 59 | 10 | 60 | 62 |
| Net Income | $-3,934 | $-4,099 | $-6,599 | $-1,869 | $-1,215 |
| EPS Basic Total Ops | -1.50 | -1.50 | -2.70 | -0.90 | -0.90 |
| EPS Basic Continuous Ops | -1.50 | -1.50 | -2.70 | -0.90 | -0.90 |
| EPS Diluted Total Ops | -1.50 | -1.50 | -2.70 | -0.90 | -0.90 |
| EPS Diluted Continuous Ops | -1.50 | -1.50 | -2.70 | -0.90 | -0.90 |
| EBITDA(a) | $-3,876 | $-3,999 | $-6,607 | $-1,922 | $-1,274 |